Most Read Articles
Tristan Manalac, 11 Jul 2018
Gestational exposure to grain products fortified with folic acid appears to be linked to a lower risk of psychosis in offspring, according to a recent study.
Pearl Toh, 10 Jul 2018
A dual-hormone artificial pancreas (DAP) with a rapid delivery of insulin and pramlintide in a fixed ratio improves glycaemic control and reduces glucose variability in adults with type 1 diabetes (T1D) compared with first-generation artificial pancreas delivering insulin alone, according to a study presented at ADA 2018.
4 days ago
Chocolate consumption is not associated with risk of coronary heart disease (CHD), stroke or both combined in postmenopausal women free of pre-existing major chronic disease, a study suggests.
Pearl Toh, 5 days ago
More intensive lowering of LDL-C levels was associated with a progressively greater survival benefit than less intensive approach, when the baseline LDL-C levels were ≥100 mg/dL, reveals a meta-analysis of 34 randomized trials.

Weight gain ups cancer risk among middle-aged individuals

11 Jul 2018

Individuals who gain weight during middle life appear to be at greater risk of developing obesity-related cancer irrespective of metabolic function and body mass index (BMI), according to a study.

Researchers examined independent and combined effects of weight gain and metabolic dysfunction during middle-adult years on obesity-related cancer risk in a cohort of 3,850 individuals (aged 45–69 years) from the Framingham Offspring Study.

Obesity-related cancer outcomes included those that involved the female reproductive organs (postmenopausal breast, uterine/endometrial and ovarian), colon, rectum, stomach, liver, gallbladder, pancreas, kidney, thyroid, oesophageal adenocarcinoma, leukaemia, non-Hodgkin lymphoma and multiple myeloma.

During about 14 years of follow up, 145 men and 90 women lost ≥0.45 kg/years (mean weight loss, –0.72 and –0.77 lbs/year, respectively), and 530 men and 805 women gained 0.45 kg/year (mean weight gain, 0.81 and 0.80 kg/year, respectively). Weight remained stable in 1,166 men and 1,112 women.

Compared with maintaining stable weight, gaining ≥0.45 kg/year over about 14 years was associated with a 38-percent increased cancer risk (hazard ratio [HR], 1.38; 95 percent CI, 1.09–1.76). Of note, the elevated cancer risk associated with weight gain increased by 77 percent in men and women with metabolic dysfunction (HR, 1.77; 1.21–2.59).

Compared with nonoverweight adults, men and women who became overweight (BMI 30 and 25 kg/m2, respectively) during midlife also had increased cancer risk (men: HR, 2.18; 1.33–3.56; women: HR, 1.60; 1.12–2.28).

The risk increased by 28 percent and 33 percent, although not significantly, in men and women who were already overweight at baseline. This is despite having a midlife BMI that was higher by 3.4 kg/m2 than the midlife BMI of those who gained weight later.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Tristan Manalac, 11 Jul 2018
Gestational exposure to grain products fortified with folic acid appears to be linked to a lower risk of psychosis in offspring, according to a recent study.
Pearl Toh, 10 Jul 2018
A dual-hormone artificial pancreas (DAP) with a rapid delivery of insulin and pramlintide in a fixed ratio improves glycaemic control and reduces glucose variability in adults with type 1 diabetes (T1D) compared with first-generation artificial pancreas delivering insulin alone, according to a study presented at ADA 2018.
4 days ago
Chocolate consumption is not associated with risk of coronary heart disease (CHD), stroke or both combined in postmenopausal women free of pre-existing major chronic disease, a study suggests.
Pearl Toh, 5 days ago
More intensive lowering of LDL-C levels was associated with a progressively greater survival benefit than less intensive approach, when the baseline LDL-C levels were ≥100 mg/dL, reveals a meta-analysis of 34 randomized trials.